Search - tctmd.com

Displaying 61 - 80 of 1332

Sort: Relevancy | Date

Presentation EuroPCR 2024

Long-term multiple comparison of transcatheter aortic valves – insights from the OBSERVANT II study

Presenter: Giuliano Costa

May 14, 2024

News Daily News

TAVI Outcomes Linked to LV Recovery in Patients With Severe Dysfunction

Michael O'Riordan

May 06, 2024

News Opinion CV Team Dispatch

May 2024 Dispatch for the CV Team

L.A. McKeown

May 01, 2024

Another Win for TAVI in Low-to-Intermediate Risk Patients

News Conference News ACC 2024

Another Win for TAVI in Patients at Low-to-Intermediate Risk: DEDICATE-DZHK6

Yael L. Maxwell

April 08, 2024

News Conference News ACC 2024

TAVI, SAVR Rates Roughly Equal for Patients Younger Than 65 in New England

Yael L. Maxwell

April 05, 2024

News Daily News

First-Ever Performance, Quality Metrics Created for Valvular and Structural Disease

Michael O'Riordan

March 20, 2024

Presentation THT Abstracts 2024

Appreciating the immediate changes in left ventricular cardiomechanics after transcatheter aortic valve replacement for moderate aortic stenosis: a case series

Presenter: Antoon van den Enden

March 05, 2024

News Daily News

Alain Cribier’s Death Mourned, His Legacy Celebrated Around the World

Shelley Wood

February 19, 2024

News Daily News

TAVI Proficiency Doesn’t Spell Success for M-TEER at Large US Sites

Michael O'Riordan

February 13, 2024

News Conference News STS 2024

SAVR After Failed TAVI on the Rise, With High Mortality

Yael L. Maxwell

February 05, 2024

News Conference News STS 2024

TAVI, SAVR Almost Equally Performed in California Patients Under 60

Yael L. Maxwell

February 01, 2024

News Features

Going Solo: Can TAVI Be Performed Without a Surgical Safety Net?

Michael O'Riordan

January 22, 2024

News Daily News

Top Structural Heart News of 2023

Todd Neale

January 02, 2024

News Conference News PCR London Valves 2023

Looking for a Winner Between Long-term TAVI Trials? Don’t, Experts Urge

Shelley Wood

November 27, 2023

News Conference News PCR London Valves 2023

Acute Decompensated Aortic Stenosis: Time for an Urgent TAVI Pathway?

Shelley Wood

November 20, 2023

News Daily News

Ross Procedure Offers ‘Excellent Survival’ 25 Years Out

Caitlin E. Cox

November 15, 2023

Presentation Cardiovascular Interventions 2023

Transcatheter Valve Technology: Where Are We Now?

Presenter: Curtiss T. Stinis

November 10, 2023

News Conference News TCT 2023

Post-TAVI Conduction Abnormalities: EP Study, Registry Data Provide Snapshots

Caitlin E. Cox

November 03, 2023

News Conference News TCT 2023

Durability, Hemodynamics Look Good for SAVR, TAVI in PARTNER 3

Michael O'Riordan

November 01, 2023

News Conference News TCT 2023

Some Surprises in Low-Risk TAVI Follow-up: PARTNER 3 and Evolut Trials

Michael O'Riordan

October 24, 2023

Advertisement

Long-term multiple comparison of transcatheter aortic valves – insights from the OBSERVANT II study

TAVI Outcomes Linked to LV Recovery in Patients With Severe Dysfunction

May 2024 Dispatch for the CV Team

Another Win for TAVI in Patients at Low-to-Intermediate Risk: DEDICATE-DZHK6

TAVI, SAVR Rates Roughly Equal for Patients Younger Than 65 in New England

First-Ever Performance, Quality Metrics Created for Valvular and Structural Disease

Appreciating the immediate changes in left ventricular cardiomechanics after transcatheter aortic valve replacement for moderate aortic stenosis: a case series

Alain Cribier’s Death Mourned, His Legacy Celebrated Around the World

TAVI Proficiency Doesn’t Spell Success for M-TEER at Large US Sites

SAVR After Failed TAVI on the Rise, With High Mortality

TAVI, SAVR Almost Equally Performed in California Patients Under 60

Going Solo: Can TAVI Be Performed Without a Surgical Safety Net?

Top Structural Heart News of 2023

Looking for a Winner Between Long-term TAVI Trials? Don’t, Experts Urge

Acute Decompensated Aortic Stenosis: Time for an Urgent TAVI Pathway?

Ross Procedure Offers ‘Excellent Survival’ 25 Years Out

Transcatheter Valve Technology: Where Are We Now?

Post-TAVI Conduction Abnormalities: EP Study, Registry Data Provide Snapshots

Durability, Hemodynamics Look Good for SAVR, TAVI in PARTNER 3

Some Surprises in Low-Risk TAVI Follow-up: PARTNER 3 and Evolut Trials

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content